Annual Cash & Cash Equivalents
$1.26 M
+$12.00 K+0.96%
December 1, 2023
Summary
- As of February 10, 2025, SKYE annual cash & cash equivalents is $1.26 million, with the most recent change of +$12.00 thousand (+0.96%) on December 1, 2023.
- During the last 3 years, SKYE annual cash & cash equivalents has fallen by -$1.21 million (-49.12%).
- SKYE annual cash & cash equivalents is now -86.01% below its all-time high of $8.98 million, reached on December 1, 2021.
Performance
SKYE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$67.41 M
-$6.71 M-9.05%
September 1, 2024
Summary
- As of February 10, 2025, SKYE quarterly cash and cash equivalents is $67.41 million, with the most recent change of -$6.71 million (-9.05%) on September 1, 2024.
- Over the past year, SKYE quarterly cash and cash equivalents has dropped by -$15.93 million (-19.11%).
- SKYE quarterly cash and cash equivalents is now -19.11% below its all-time high of $83.34 million, reached on March 1, 2024.
Performance
SKYE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SKYE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.0% | -19.1% |
| 3 y3 years | -49.1% | +10000.0% |
| 5 y5 years | -32.2% | +10000.0% |
SKYE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.0% | +1.0% | -19.1% | >+9999.0% |
| 5 y | 5-year | -86.0% | +1.0% | -19.1% | >+9999.0% |
| alltime | all time | -86.0% | +4659.5% | -19.1% | >+9999.0% |
Skye Bioscience Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $67.41 M(-9.1%) |
| Jun 2024 | - | $74.12 M(-11.1%) |
| Mar 2024 | - | $83.34 M(+6532.9%) |
| Dec 2023 | $1.26 M(+1.0%) | $1.26 M(-75.5%) |
| Sep 2023 | - | $5.13 M(+826.3%) |
| Jun 2023 | - | $553.40 K(-79.3%) |
| Mar 2023 | - | $2.67 M(+114.4%) |
| Dec 2022 | $1.24 M(-86.1%) | $1.24 M(+199.6%) |
| Sep 2022 | - | $415.40 K(-85.8%) |
| Jun 2022 | - | $2.93 M(-51.2%) |
| Mar 2022 | - | $6.01 M(-33.1%) |
| Dec 2021 | $8.98 M(+263.8%) | $8.98 M(-19.0%) |
| Sep 2021 | - | $11.09 M(+113.8%) |
| Jun 2021 | - | $5.19 M(+0.7%) |
| Mar 2021 | - | $5.15 M(+108.6%) |
| Dec 2020 | $2.47 M(+34.9%) | $2.47 M(-41.5%) |
| Sep 2020 | - | $4.22 M(+4021.6%) |
| Jun 2020 | - | $102.50 K(-81.8%) |
| Mar 2020 | - | $563.90 K(-69.2%) |
| Dec 2019 | $1.83 M(-1.3%) | $1.83 M(+38.7%) |
| Sep 2019 | - | $1.32 M(-53.0%) |
| Jun 2019 | - | $2.81 M(-36.4%) |
| Mar 2019 | - | $4.41 M(+138.1%) |
| Dec 2018 | $1.85 M | $1.85 M(+75.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $1.06 M(-43.5%) |
| Jun 2018 | - | $1.87 M(-36.3%) |
| Mar 2018 | - | $2.95 M(+1032.8%) |
| Dec 2017 | $260.00 K(+301.2%) | $260.00 K(+519.0%) |
| Sep 2017 | - | $42.00 K(-61.4%) |
| Jun 2017 | - | $108.90 K(-71.4%) |
| Mar 2017 | - | $380.30 K(+486.9%) |
| Dec 2016 | $64.80 K(-98.0%) | $64.80 K(-79.7%) |
| Sep 2016 | - | $319.90 K(-61.5%) |
| Jun 2016 | - | $831.70 K(-59.7%) |
| Mar 2016 | - | $2.06 M(-36.0%) |
| Dec 2015 | $3.22 M(+1453.9%) | $3.22 M(-25.8%) |
| Sep 2015 | - | $4.34 M(+622.2%) |
| Jun 2015 | - | $601.30 K(+240.3%) |
| Mar 2015 | - | $176.70 K(-14.8%) |
| Dec 2014 | $207.30 K(+297.1%) | $207.30 K(-79.8%) |
| Sep 2014 | - | $1.02 M(+2514.8%) |
| Jul 2014 | - | $39.20 K(-21.6%) |
| Apr 2014 | - | $50.00 K(+7.5%) |
| Jan 2014 | - | $46.50 K(-10.9%) |
| Oct 2013 | $52.20 K(+97.7%) | $52.20 K(+40.3%) |
| Jul 2013 | - | $37.20 K(+25.3%) |
| Apr 2013 | - | $29.70 K(+12.5%) |
| Oct 2012 | $26.40 K | $26.40 K |
FAQ
- What is Skye Bioscience annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Skye Bioscience?
- What is Skye Bioscience annual cash & cash equivalents year-on-year change?
- What is Skye Bioscience quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Skye Bioscience?
- What is Skye Bioscience quarterly cash and cash equivalents year-on-year change?
What is Skye Bioscience annual cash & cash equivalents?
The current annual cash & cash equivalents of SKYE is $1.26 M
What is the all time high annual cash & cash equivalents for Skye Bioscience?
Skye Bioscience all-time high annual cash & cash equivalents is $8.98 M
What is Skye Bioscience annual cash & cash equivalents year-on-year change?
Over the past year, SKYE annual cash & cash equivalents has changed by +$12.00 K (+0.96%)
What is Skye Bioscience quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SKYE is $67.41 M
What is the all time high quarterly cash and cash equivalents for Skye Bioscience?
Skye Bioscience all-time high quarterly cash and cash equivalents is $83.34 M
What is Skye Bioscience quarterly cash and cash equivalents year-on-year change?
Over the past year, SKYE quarterly cash and cash equivalents has changed by -$15.93 M (-19.11%)